ABVX

Abivax S.A.

• Seeking Alpha·08/08 19:28

  SA Asks: What's the outlook for Big Pharma M&A?

• Seeking Alpha·08/07 21:58

  HQH: After Biotech's Breakout Year, This Healthcare CEF Still Trades Below NAV; Buy

• NASDAQ·08/06 15:22

  VGK, ABVX, BORR: Large Outflows Detected at ETF

• TipRanks·07/30 21:10

  Abivax announces positive pre-NDA interaction with FDA for obefazimod in UC

• Benzinga·07/30 20:19

  Abivax Completes Pre-New Drug Application Interaction For Obefazimod With FDA To Treat Adults With Moderately To Severely Active Ulcerative Colitis

• TipRanks·07/24 13:25

  Abivax price target raised to $180 from $132 at Morgan Stanley

• Benzinga·07/23 18:06

  Palisade Bio Analyst Sees Lead Drug Can Potentially Bridge Gap in Ulcerative Colitis

• Seeking Alpha·07/23 15:13

  Palisade Bio jumps following Oppenheimer outperform initiation

• TipRanks·07/17 18:10

  Abivax re-engages Centerview amid renewed takeover interest, La Lettre says

• Benzinga·07/17 18:04

  'Biotech Abivax re-engages investment bank Centerview for Big Pharma takeover talks' - La Lettre

• Seeking Alpha·07/16 14:25

  Abivax: Obefazimod Goes The Distance And So Does My Buy Rating

• TipRanks·07/13 12:04

  U.S. Chess Champion Backs Out Of Abivax and Casey’s, But Keeps Outpacing the S&P 500

• Benzinga·07/09 15:59

  Piper Sandler Maintains Overweight on Abivax, Raises Price Target to $175

• TipRanks·07/09 11:21

  Abivax price target raised to $175 from $165 at Piper Sandler

• TipRanks·07/06 12:45

  Abivax SA Sponsored ADR (ABVX) Gets a Hold from Wedbush